Mindray Medical's Q3 Financial Report Disappoints

Published: Nov 08, 2012

by Richard Daverman, PhD

November 7, 2012 -- Mindray Medical reported that its Q2 revenues rose 18% to $257 million, with non-GAAP net income up an equal 18% at $50 million. Unfortunately, those results were below analysts’ estimates. Also, a $10 million charge took EBITDA and net income lower than the prior year’s similar period. The charge derives from a pricing dispute with a supplier over costs for components of patient monitors sold in the US. More details....

Stock Symbol: (NYSE: MR)

Back to news